The files are dated between 2017 and August 2022, the vendor said. The leak amounts to 2.4 terabyte of data, including 335,000 emails, and it involves more than a half million users, according to SOCRadar. SOCRadar said that a "single misconfigured data bucket" was responsible the exposure of the data of the 65,000 affected companies, which the company said are based across 111 countries. Financial terms were not disclosed.Īffected data may have included "names, email addresses, email content, company name, and phone numbers, and may have included attached files relating to business between a customer and Microsoft or an authorized Microsoft partner," Microsoft said. The IBM transaction is expected to close in Q2 of this year, subject to regulatory clearances. That deal could create its own set of challenges for Oracle. The IBM sale stands in stark contrast to Oracle’s recent $28.3 billion acquisition of health data and technology company Cerner, a deal that in many ways revolves around what Watson Health promised: spinning massive amounts of unstructured health data into algorithmic models and insights to advance medicine and help improve day-to-day health care and hospital operations - all in the cloud. They’re winning our contracts, taking our customers, doing better at AI,” the engineer told the publication. “Smaller companies are eating us alive,” said one staff member. Phytel engineers told IEEE Spectrum at the time that Phytel’s customer base was split nearly in half from 150 clients to 80 after IBM acquired the company. Then, just a few years later in 2018, reports emerged of layoffs at IBM’s acquired health units including data analytics company Truven, medical imaging company Merge and patient management company Phytel.
In 2015, when the company launched its Watson Health division, it did so with gusto - snapping up other health data and analytics providers and partnering with hospitals and big names like Apple, Johnson & Johnson and Medtronic. From the start over a decade ago, IBM touted the health care analytics capabilities of Watson, its massive AI platform.
Whatson health software#
IBM Software SVP Tom Rosamilia called the sale a move to align the company with its “hybrid cloud and AI strategy,” rather than a signal that the company has given up on its massive AI platform Watson, or its health care IT business more broadly.īut it’s difficult not to see the sale as a failure of IBM’s big bet on Watson to usher health care into the AI age. The highly anticipated sell-off includes data sets and analytics products such as Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex and imaging software offerings. IBM announced today that it has sold its Watson Health data and analytics assets to private equity firm Francisco Partners.
0 kommentar(er)
